Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
80.3M
-
Shares change
-
+7.06M
-
Total reported value, excl. options
-
$1.64B
-
Value change
-
+$187M
-
Put/Call ratio
-
0.06
-
Number of buys
-
140
-
Number of sells
-
-111
-
Price
-
$20.46
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q1 2019
280 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q1 2019.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.3M shares
of 129M outstanding shares and own 62.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13.8M shares), VANGUARD GROUP INC (5.77M shares), JANUS HENDERSON GROUP PLC (5.1M shares), EAGLE ASSET MANAGEMENT INC (2.71M shares), BROWN ADVISORY INC (2.52M shares), STATE STREET CORP (2.35M shares), CARILLON TOWER ADVISERS, INC. (2M shares), EMERALD ADVISERS, LLC (1.88M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.88M shares), and Bank of New York Mellon Corp (1.83M shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.